A court in the Northern District of Illinois recently denied a motion to dismiss a lawsuit alleging that the alleged inclusion of artificial citric acid in a product rendered the “No Artificial Flavors, Preservatives, or Dyes” representation on the front label false and/or misleading.  Hayes v. Kraft Heinz Co., 2024 WL 4766319 (N.D. Ill. Nov. 13, 2024). 

The court first held that plaintiffs sufficiently alleged that the citric acid was artificial.  Plaintiffs’ complaint cited articles explaining, for example, “the history of citric acid and how the artificial variety derived from Aspergillus niger has overtaken the natural variety.”  The court found that such allegations provided “a sufficient connection between the industry practice of using artificial citric acid” and the defendant’s alleged practices.  The court also distinguished Valencia v. Snapple Beverage Corp., 2024 WL 1158476 (S.D.N.Y. Mar. 18, 2024), which we previously covered here.  The court in Valencia dismissed plaintiff’s claims in part because that plaintiff did not allege how “artificial” citric acid derived from Aspergillus niger is chemically different from “natural” citric acid derived from fruits.  In this case, however, the court concluded plaintiffs had so alleged. 

The court then held that plaintiffs sufficiently alleged that the citric acid in the product functioned as a preservative.  The court credited plaintiffs’ citation of scholarly articles describing citric acid’s role in preserving food, as well as FDA guidance that describes citric acid as a preservative.  This decision marks a deviation from a recent run of cases in other courts that have dismissed citric and malic acid complaints, including on some of the same grounds that were asserted here.  In addition to Valencia, we have covered those cases here and here.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Cort Lannin Cort Lannin

Cortlin Lannin is a litigator who defends clients in high-stakes consumer and antitrust class action matters. Described by Chambers USA as “smart, detail-oriented and thorough,” Cort has an extensive track record of defeating false advertising, privacy, and competition-related claims.

Cort has defended many…

Cortlin Lannin is a litigator who defends clients in high-stakes consumer and antitrust class action matters. Described by Chambers USA as “smart, detail-oriented and thorough,” Cort has an extensive track record of defeating false advertising, privacy, and competition-related claims.

Cort has defended many of the world’s largest consumer companies from class action litigation. This includes cases alleging false advertising, deceptive trade practices, and privacy violations under California’s UCL and CLRA, New York’s GBL, and other states’ laws. He is experienced at heading off cases before any complaint is filed, successfully dismissing complaints at the pleading stage, and defeating class certification. The Daily Journal has recognized Cort as achieving a “Top Verdict” and as one of California’s Top 100 lawyers, noting that “he has developed a track record of securing dismissals in consumer class action cases before discovery begins—a feat that remains uncommon in a practice area where courts typically allow plaintiffs broad latitude to develop their theories.” He is also an editor of the firm’s Inside Class Actions blog and regularly contributes analyses of new class action decisions and developments.

Cort is also a co-chair of the firm’s Cartel Defense Practice Group and represents companies and individuals facing criminal and civil antitrust investigations, including before the DOJ Antitrust Division and FTC. He has defended his clients in cases implicating the high-tech industry, alleged “no-poach” and wage-fixing agreements, price-fixing, and similar conduct. For his accomplishments, he has twice been recognized as a Top Antitrust Lawyer by the Daily Journal.

Cort maintains an active pro bono practice and is a co-chair of Covington’s CovPride Resource Group.

Watch: Cort provides insights on class action litigation, as part of our Navigating Class Actions video series.

 

Photo of Kaixin Fan Kaixin Fan

Kaixin Fan is a member of the Food, Drug, and Device Practice Group. She advises pharmaceutical, biotechnology, and medical device companies as well as trade associations in regulatory matters. She has experience in matters relating to FDA informed consent requirements, advertising and promotion…

Kaixin Fan is a member of the Food, Drug, and Device Practice Group. She advises pharmaceutical, biotechnology, and medical device companies as well as trade associations in regulatory matters. She has experience in matters relating to FDA informed consent requirements, advertising and promotion issues, and other aspects of U.S. federal and state regulation of pharmaceuticals, biologics, and medical devices. Kaixin also assists clients in navigating complex regulatory matters in China, and works closely with local counsel in other Asia-Pacific jurisdictions. She has supported life science transactions by evaluating regulatory compliance of companies and advising on commercial agreements.

Kaixin maintains an active pro bono practice, with experience in the areas of housing, reproductive rights, and gender-based violence.